On October 19, Gossamer Bio Inc Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Portfolio Pulse from Benzinga Newsdesk
Gossamer Bio Inc has received a notice of delisting or failure to satisfy a continued listing rule or standard from Nasdaq, according to an SEC filing.

October 20, 2023 | 8:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Gossamer Bio Inc has been notified by Nasdaq about a potential delisting due to failure to meet a continued listing rule or standard.
Receiving a delisting notice from a major exchange like Nasdaq is a serious issue for any publicly traded company. It indicates that the company is not meeting certain standards required to maintain its listing, which could be related to financial, governance, or other issues. This news is likely to negatively impact investor sentiment and could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100